Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1089/mab.2020.0041 http://scihub22266oqcxt.onion/10.1089/mab.2020.0041 33513050!ä!33513050 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Monoclon+Antib+Immunodiagn+Immunother 2021 ; 40 (1): 17-20 Nephropedia Template TP {{tp|p=33513050|t=2021. How IvIg Can Mitigate Covid-19 Disease: A Symmetrical Immune Network Model |pdf=|usr=}}{{33513050}} gab.com Text How IvIg Can Mitigate Covid-19 Disease: A Symmetrical Immune Network Model JO: Monoclon Antib Immunodiagn Immunother http://www.kidney.de/pget.php?&tw=1&pmid=33513050 #FOAvip In this report we provide a hypothesis of how intravenous immunoglobulin (IvIg) (pooled therapeutic normal IgG) mitigates the severe disease after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. The disease is caused by an overreaction of the innate immune system producing a cytokine storm and inflicting multiple organ damage. Our interpretation of IvIg therapy hinges on a recent analysis of the immune dysregulation in Covid-19 infection. Previous infections with common cold coronavirus induce suppressor memory B cells that inhibit an immune response to Covid-19. The repertoire of natural antibodies (IvIg) contains suppressing antibodies in a symmetrically balanced network structure. When this repertoire interacts with the imbalanced network in the infected patient, it can neutralize the suppression of an antibody response against Covid-19. The described scenario for IvIg in Covid-19 infection may also apply in the therapy of autoimmune diseases. Twit Text FOAVip How IvIg Can Mitigate Covid-19 Disease: A Symmetrical Immune Network Model ????Monoclon Antib Immunodiagn Immunother http://www.kidney.de/pget.php?&tw=1&pmid=33513050 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33513050 #FOAvip English Wikipedia <ref>{{Cite pmid|33513050}}</ref> How IvIg Can Mitigate Covid-19 Disease: A Symmetrical Immune Network Model #MMPMID33513050 Kohler H; Kaveri S Monoclon Antib Immunodiagn Immunother 2021[Feb]; 40 (1): 17-20 PMID33513050show ga In this report we provide a hypothesis of how intravenous immunoglobulin (IvIg) (pooled therapeutic normal IgG) mitigates the severe disease after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. The disease is caused by an overreaction of the innate immune system producing a cytokine storm and inflicting multiple organ damage. Our interpretation of IvIg therapy hinges on a recent analysis of the immune dysregulation in Covid-19 infection. Previous infections with common cold coronavirus induce suppressor memory B cells that inhibit an immune response to Covid-19. The repertoire of natural antibodies (IvIg) contains suppressing antibodies in a symmetrically balanced network structure. When this repertoire interacts with the imbalanced network in the infected patient, it can neutralize the suppression of an antibody response against Covid-19. The described scenario for IvIg in Covid-19 infection may also apply in the therapy of autoimmune diseases. |*COVID-19 Drug Treatment[MESH] |*Models, Immunological[MESH] |Adaptive Immunity[MESH] |COVID-19/*immunology[MESH] |Cytokine Release Syndrome/immunology/prevention & control[MESH] |Humans[MESH] |Immunoglobulins, Intravenous/*therapeutic use[MESH]How IvIg Can Mitigate Covid-19 Disease: A Symmetrical Immune Network M(epmc).pdf DeepDyve Pubget Overpricing